Cargando…
P1350: THE EFFICACY OF UPFRONT HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION IN DECREASING RELAPSE RATE IN IV STAGE AND HIGH-INTERMEDIATE/HIGH IPI RISK GROUPS DLBCL
| Autores principales: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430834/ http://dx.doi.org/10.1097/01.HS9.0000848264.70663.5a |
| _version_ | 1784779885252706304 |
|---|---|
| author | Koviazin, A. Filatova, L. Zyuzgin, I. Artemyeva, A. Motalkina, M. Chudinovskikh, Y. Volchenkov, S. Poliatskin, I. Dobrovolskaya, E. Shalaev, S. Ishmatova, I. Zverkova, A. Burda, D. Elkhova, S. Semiglazova, T. |
| author_facet | Koviazin, A. Filatova, L. Zyuzgin, I. Artemyeva, A. Motalkina, M. Chudinovskikh, Y. Volchenkov, S. Poliatskin, I. Dobrovolskaya, E. Shalaev, S. Ishmatova, I. Zverkova, A. Burda, D. Elkhova, S. Semiglazova, T. |
| author_sort | Koviazin, A. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9430834 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94308342022-08-31 P1350: THE EFFICACY OF UPFRONT HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION IN DECREASING RELAPSE RATE IN IV STAGE AND HIGH-INTERMEDIATE/HIGH IPI RISK GROUPS DLBCL Koviazin, A. Filatova, L. Zyuzgin, I. Artemyeva, A. Motalkina, M. Chudinovskikh, Y. Volchenkov, S. Poliatskin, I. Dobrovolskaya, E. Shalaev, S. Ishmatova, I. Zverkova, A. Burda, D. Elkhova, S. Semiglazova, T. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9430834/ http://dx.doi.org/10.1097/01.HS9.0000848264.70663.5a Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Koviazin, A. Filatova, L. Zyuzgin, I. Artemyeva, A. Motalkina, M. Chudinovskikh, Y. Volchenkov, S. Poliatskin, I. Dobrovolskaya, E. Shalaev, S. Ishmatova, I. Zverkova, A. Burda, D. Elkhova, S. Semiglazova, T. P1350: THE EFFICACY OF UPFRONT HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION IN DECREASING RELAPSE RATE IN IV STAGE AND HIGH-INTERMEDIATE/HIGH IPI RISK GROUPS DLBCL |
| title | P1350: THE EFFICACY OF UPFRONT HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION IN DECREASING RELAPSE RATE IN IV STAGE AND HIGH-INTERMEDIATE/HIGH IPI RISK GROUPS DLBCL |
| title_full | P1350: THE EFFICACY OF UPFRONT HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION IN DECREASING RELAPSE RATE IN IV STAGE AND HIGH-INTERMEDIATE/HIGH IPI RISK GROUPS DLBCL |
| title_fullStr | P1350: THE EFFICACY OF UPFRONT HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION IN DECREASING RELAPSE RATE IN IV STAGE AND HIGH-INTERMEDIATE/HIGH IPI RISK GROUPS DLBCL |
| title_full_unstemmed | P1350: THE EFFICACY OF UPFRONT HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION IN DECREASING RELAPSE RATE IN IV STAGE AND HIGH-INTERMEDIATE/HIGH IPI RISK GROUPS DLBCL |
| title_short | P1350: THE EFFICACY OF UPFRONT HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION IN DECREASING RELAPSE RATE IN IV STAGE AND HIGH-INTERMEDIATE/HIGH IPI RISK GROUPS DLBCL |
| title_sort | p1350: the efficacy of upfront high-dose chemotherapy with autologous stem cell transplantation in decreasing relapse rate in iv stage and high-intermediate/high ipi risk groups dlbcl |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430834/ http://dx.doi.org/10.1097/01.HS9.0000848264.70663.5a |
| work_keys_str_mv | AT koviazina p1350theefficacyofupfronthighdosechemotherapywithautologousstemcelltransplantationindecreasingrelapserateinivstageandhighintermediatehighipiriskgroupsdlbcl AT filatoval p1350theefficacyofupfronthighdosechemotherapywithautologousstemcelltransplantationindecreasingrelapserateinivstageandhighintermediatehighipiriskgroupsdlbcl AT zyuzgini p1350theefficacyofupfronthighdosechemotherapywithautologousstemcelltransplantationindecreasingrelapserateinivstageandhighintermediatehighipiriskgroupsdlbcl AT artemyevaa p1350theefficacyofupfronthighdosechemotherapywithautologousstemcelltransplantationindecreasingrelapserateinivstageandhighintermediatehighipiriskgroupsdlbcl AT motalkinam p1350theefficacyofupfronthighdosechemotherapywithautologousstemcelltransplantationindecreasingrelapserateinivstageandhighintermediatehighipiriskgroupsdlbcl AT chudinovskikhy p1350theefficacyofupfronthighdosechemotherapywithautologousstemcelltransplantationindecreasingrelapserateinivstageandhighintermediatehighipiriskgroupsdlbcl AT volchenkovs p1350theefficacyofupfronthighdosechemotherapywithautologousstemcelltransplantationindecreasingrelapserateinivstageandhighintermediatehighipiriskgroupsdlbcl AT poliatskini p1350theefficacyofupfronthighdosechemotherapywithautologousstemcelltransplantationindecreasingrelapserateinivstageandhighintermediatehighipiriskgroupsdlbcl AT dobrovolskayae p1350theefficacyofupfronthighdosechemotherapywithautologousstemcelltransplantationindecreasingrelapserateinivstageandhighintermediatehighipiriskgroupsdlbcl AT shalaevs p1350theefficacyofupfronthighdosechemotherapywithautologousstemcelltransplantationindecreasingrelapserateinivstageandhighintermediatehighipiriskgroupsdlbcl AT ishmatovai p1350theefficacyofupfronthighdosechemotherapywithautologousstemcelltransplantationindecreasingrelapserateinivstageandhighintermediatehighipiriskgroupsdlbcl AT zverkovaa p1350theefficacyofupfronthighdosechemotherapywithautologousstemcelltransplantationindecreasingrelapserateinivstageandhighintermediatehighipiriskgroupsdlbcl AT burdad p1350theefficacyofupfronthighdosechemotherapywithautologousstemcelltransplantationindecreasingrelapserateinivstageandhighintermediatehighipiriskgroupsdlbcl AT elkhovas p1350theefficacyofupfronthighdosechemotherapywithautologousstemcelltransplantationindecreasingrelapserateinivstageandhighintermediatehighipiriskgroupsdlbcl AT semiglazovat p1350theefficacyofupfronthighdosechemotherapywithautologousstemcelltransplantationindecreasingrelapserateinivstageandhighintermediatehighipiriskgroupsdlbcl |